February 2025: Revolutionizing Women's Health

Nettle™ by Samphire Neuroscience: A non-invasive, drug-free solution for women's health.

Image: Samphire Neuroscience

We are thrilled to spotlight Nettle™, a groundbreaking wearable device that is transforming women’s health. Developed by Samphire Neuroscience, Nettle™ uses transcranial direct current stimulation (tDCS) to alleviate common menstrual symptoms such as pain, mood swings, and fatigue.

Clinically proven to improve well-being, Nettle™ offers a non-invasive, drug-free alternative to traditional treatments. By gently modulating brain activity, Nettle™ helps women manage their menstrual health more effectively and comfortably. Now available on the market, this innovative device is empowering women to take control of their health with ease.

With its successful launch, Nettle™ is setting a new standard in menstrual health solutions. Experience the future of women’s health today!

About Samphire Neuroscience

Samphire Neuroscience is a pioneering medtech company focused on advancing women’s health through innovative, non-invasive technologies. The company is dedicated to addressing critical health challenges by developing cutting-edge solutions that improve well-being and quality of life. With a strong emphasis on scientific research and technological innovation, Samphire Neuroscience is committed to providing women with safe, effective, and accessible healthcare solutions.

Sam Draper
February 1, 2025

February 2025

Innovation of the Month

Do you want to discover more, visit the website
Visit Website

Other news

How Thin Cell Batteries Are Revolutionizing the Wearable Industry

Thin cell batteries are among some of the smallest batteries around.

These AR Glasses Can Translate Languages and Detect Images

New ‘Frame’ AR glasses from Brilliant Labs uses artificial intelligence.

ArcX Smart Ring Lets You Control Your Phone Via Bluetooth

When you’re running or cycling, it’s difficult to answer call or change the song you’re listening...

Healthtech Startup Ultrahuman Raises $17.5M In Series B Funding

Health technology startup Ultrahuman has raised $17.5 million in series B funding round backed ...
Discover more